Cyclosporine trough levels comparison with AUC during conversion to microemulsion formulation (''Neoral'').

被引：0
|
作者：
Heifets, M
Sellers, P
Sallas, W
Browne, B
Samuels, LA
Cooney, G
机构：
[1] TEMPLE UNIV HOSP & MED SCH, DEPT MED, PHILADELPHIA, PA 19140 USA
[2] TEMPLE UNIV HOSP & MED SCH, DEPT SURG, PHILADELPHIA, PA 19140 USA
[3] TEMPLE UNIV HOSP & MED SCH, DEPT PHARM, PHILADELPHIA, PA 19140 USA
[4] SANDOZ RES INST, E HANOVER, NJ USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A3322 / A3322
页数：1
相关论文
共 50 条
  • [31] Cyclosporine dose, blood levels, and renal allograft function after conversion from Sandimmune to Neoral.
    Schmouder, RL
    Rossi, SJ
    Henry, SL
    Leichtman, AB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3378 - A3378
  • [32] Renal dysfunction in paediatric liver transplant recipients on cyclosporine: A comparison between neoral and sandimmun formulation.
    不详
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 40 (05): : 672 - 673
  • [33] Renal dysfunction in paediatric liver transplant recipients on cyclosporine: A comparison between neoral and sandimmun formulation.
    Chai, PF
    van Mourik, IDM
    Lloyd, C
    Davies, P
    Kelly, DA
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 109 - 109
  • [34] Comparison of two cyclosporine formulations in healthy volunteers: Bioequivalence of the new Sang-35 formulation and neoral
    Schroeder, TJ
    Cho, MJ
    Pollack, GM
    Floc'h, R
    Moran, HB
    Levy, R
    Moore, LW
    Pouletty, P
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (09): : 807 - 814
  • [35] Retrospective pharmacoeconomic study of the use of cyclosporine a microemulsion (Sandimmun® Neoral®) in comparison with tacrolimus (Prograf®) for immunosuppression following kidney transplantation
    Tolkushin, A. G.
    Kulikov, A.
    Yagudina, R., I
    Morozov, A.
    VALUE IN HEALTH, 2007, 10 (06) : A314 - A315
  • [36] Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function
    Konstadinidou, I
    Boletis, JN
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 163S - 166S
  • [37] Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine:: A double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics
    Anderson, IF
    Helve, T
    Hannonen, P
    Leirisalo-Repo, M
    Gilboe, IM
    Nissilä, M
    Keystone, EC
    Kraag, GR
    Bjorneboe, O
    Chalmers, A
    Dovland, H
    Mueller, E
    Richard, F
    Whatmough, I
    Schmidt, AG
    Kovarik, JM
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (03) : 556 - 562
  • [38] Cyclosporine peak levels provide a better correlation with the area-under-the-curve than trough levels in liver transplant patients treated with neoral
    Cantarovich, M
    Barkun, J
    Besner, JG
    Metrakos, P
    Alpert, E
    Deschénes, M
    Aalamian, Z
    Tchervenkov, JI
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1462 - 1463
  • [39] The impact of (1:1) cyclosporine A conversion to its microemulsion formulation on the kidney function of patients with cardiac allografts
    Khajehdehi, P
    Yip, D
    Bastani, B
    CLINICAL TRANSPLANTATION, 1999, 13 (02) : 176 - 180
  • [40] Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on Sandimmun Neoral
    Al Wakeel, J. S.
    Shaheen, F. A. M.
    Mathew, M. C.
    Abou Zeinab, H. M.
    Al Alfi, A.
    Tarif, N. M.
    Al Mousawi, M. S. A.
    Mahmoud, T. S.
    Alorrayed, A. S.
    Fagir, E. A.
    Dham, R. S.
    Shaker, D. S.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (07) : 2245 - 2251
12345